{"schema_version":"secwatch.filing_event.v1","accession":"0001799191-23-000037","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.284053+00:00","generated_at":"2026-06-11T18:41:35.123595+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"low","headline":"Oncology Institute releases Q2 2023 results and 2023 guidance; no specific figures in filing text","bullets":["Company furnished slide presentation with Q2 and H1 2023 financial results on August 10, 2023.","Management provided updated business guidance for the year ending December 31, 2023.","No revenue, EPS, or other numeric details are extractable from the available filing exhibits.","Tickers: TOI (common stock) and TOIIW (warrants)."],"urls":{"canonical":"https://secwatch.observer/filing/0001799191-23-000037","json":"https://secwatch.observer/filing/0001799191-23-000037.json","markdown":"https://secwatch.observer/filing/0001799191-23-000037.md","text":"https://secwatch.observer/filing/0001799191-23-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/0001799191-23-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/toi-20230810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T18:41:35.123595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81e9392d62aa9decb0e53f9533f2bda77b43e1f9","claim":"Oncology Institute, Inc. reported financial results for the three months ended June 30, 2023.","evidence_excerpt":"On August 10, 2023, The Oncology Institute, Inc. (the \"Company\") issued a slide presentation which includes the Company's financial results for the three months and six months ended June 30, 2023 and certain other financial information.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/0001799191-23-000037-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"92364412a860169a323aa942215fe5e31df283b5","claim":"Oncology Institute, Inc. reported financial results for the six months ended June 30, 2023.","evidence_excerpt":"On August 10, 2023, The Oncology Institute, Inc. (the \"Company\") issued a slide presentation which includes the Company's financial results for the three months and six months ended June 30, 2023 and certain other financial information.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919123000037/0001799191-23-000037-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the six months ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}